Q2 2025 |
178 |
$512M |
+$33.5M |
-$16.1M |
+$17.4M |
COST, IVW, AAPL, NVDA, IVE
|
13F-HR |
7/23/2025, 01:05 PM |
Q1 2025 |
173 |
$447M |
+$21.8M |
-$16.3M |
+$5.5M |
COST, IVW, IVE, AAPL, AGG
|
13F-HR |
4/23/2025, 01:59 PM |
Q4 2024 |
171 |
$457M |
+$80.2M |
-$41.1M |
+$39.1M |
COST, IVW, AAPL, IVE, NVDA
|
13F-HR |
2/11/2025, 11:05 AM |
Q3 2024 |
164 |
$442M |
+$21M |
-$28M |
-$7.02M |
IVE, COST, IVW, AAPL, AGG
|
13F-HR |
12/19/2024, 02:12 PM |
Q2 2024 |
168 |
$436M |
+$25.8M |
-$11.7M |
+$14.1M |
IVE, IVW, COST, AGG, AAPL
|
13F-HR |
12/19/2024, 02:11 PM |
Q1 2024 |
171 |
$421M |
+$27.5M |
-$18.7M |
+$8.82M |
IVE, IVW, COST, AGG, GVI
|
13F-HR |
12/19/2024, 02:09 PM |
Q4 2023 |
166 |
$390M |
+$27.6M |
-$36.5M |
-$8.87M |
IVE, IVW, COST, AGG, AAPL
|
13F-HR |
12/19/2024, 01:30 PM |
Q3 2023 |
199 |
$363M |
+$35.8M |
-$29M |
+$6.74M |
IVE, IVW, COST, AGG, GVI
|
13F-HR |
12/19/2024, 01:29 PM |
Q2 2023 |
218 |
$371M |
+$26.1M |
-$12.6M |
+$13.5M |
IVE, COST, IVW, AGG, AAPL
|
13F-HR |
12/19/2024, 01:27 PM |
Q1 2023 |
210 |
$339M |
+$12.3M |
-$18M |
-$5.74M |
IVE, COST, AGG, IVW, GVI
|
13F-HR |
12/19/2024, 01:26 PM |
Q4 2022 |
213 |
$328M |
+$29.3M |
-$25M |
+$4.34M |
IVE, AGG, COST, IVW, GVI
|
13F-HR |
12/19/2024, 01:19 PM |
Q3 2022 |
208 |
$305M |
+$18.4M |
-$14.5M |
+$3.84M |
IVE, COST, AGG, IVW, GVI
|
13F-HR |
12/19/2024, 01:17 PM |
Q2 2022 |
216 |
$321M |
+$31M |
-$41.4M |
-$10.4M |
IVE, COST, AGG, IVW, GVI
|
13F-HR |
12/19/2024, 01:15 PM |
Q1 2022 |
212 |
$392M |
+$16.5M |
-$14.8M |
+$1.73M |
IVE, IVW, COST, AGG, AAPL
|
13F-HR |
12/19/2024, 01:13 PM |
Q4 2021 |
225 |
$424M |
+$17.8M |
-$24.4M |
-$6.59M |
IVE, IVW, AGG, COST, AAPL
|
13F-HR |
12/19/2024, 11:21 AM |
Q3 2021 |
211 |
$403M |
+$24M |
-$22.1M |
+$1.92M |
IVE, IVW, AGG, COST, GVI
|
13F-HR |
12/19/2024, 11:20 AM |
Q2 2021 |
201 |
$412M |
+$40.6M |
-$12.9M |
+$27.8M |
IVE, IVW, AGG, GVI, ITOT
|
13F-HR |
12/19/2024, 11:18 AM |
Q1 2021 |
188 |
$364M |
+$41.7M |
-$8.38M |
+$33.3M |
IVE, IVW, AGG, GVI, ITOT
|
13F-HR |
12/19/2024, 11:16 AM |
Q4 2020 |
178 |
$320M |
+$47.3M |
-$9.62M |
+$37.7M |
IVE, IVW, AGG, ITOT, GVI
|
13F-HR |
12/19/2024, 09:23 AM |
Q3 2020 |
159 |
$262M |
+$30.3M |
-$13.7M |
+$16.6M |
IVE, IVW, AGG, ITOT, GVI
|
13F-HR |
12/19/2024, 09:21 AM |
Q2 2020 |
151 |
$234M |
+$24.8M |
-$6.57M |
+$18.3M |
IVE, IVW, AGG, ITOT, GVI
|
13F-HR |
12/19/2024, 09:20 AM |
Q1 2020 |
127 |
$181M |
+$9.01M |
-$17.9M |
-$8.84M |
IVE, IVW, AGG, ITOT, GVI
|
13F-HR |
12/19/2024, 09:15 AM |
Q4 2019 |
155 |
$226M |
$0 |
$0 |
|
IVE, IVW, ITOT, AGG, IJH
|
13F-HR |
12/13/2024, 12:06 PM |